Loading…
Loading…
Sentiment · FY2026 Q1
| Analyst | Firm | Questions | ChallengePercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|---|
| Rick Safran | Seaport Research Partners | 5 | 0% |
| Kristine Liwag | Morgan Stanley | 5 | 0% |
| Gautam Khanna | TD Cowen | 5 | 0% |
| Mike Ciarmoli | Truist Securities | 4 | 0% |
| Scott Mikus | Melius Research | 4 | 0% |
| Ron Epstein | Bank of America | 4 | 25% |
| Rob Stallard | Vertical Research Partners | 4 | 25% |
| Myles Walton | Wolfe Research | 4 | 50% |
| Doug Harned | Bernstein | 4 | 75% |
| Scott Deuschle | Deutsche Bank | 4 | 25% |
| Firm | Analysts | Questions | ChallengePercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|---|
| TD Cowen | 1 | 5 | 0% |
| Seaport Research Partners | 1 | 5 | 0% |
| Morgan Stanley | 1 | 5 | 0% |
| Bernstein |
| 1 |
| 4 |
| 75% |
| Deutsche Bank | 1 | 4 | 25% |
| Melius Research | 1 | 4 | 0% |
| Bank of America | 1 | 4 | 25% |
| Truist Securities | 1 | 4 | 0% |
Sales of $18 billion were in line with the prior year as F-16 and C-130 program losses pressured Aeronautics margins, while EPS of $6.44 declined 12% against tough prior-year comparisons. Munitions production ramp accelerated with $7 billion in PAC-3 contract awards, and F-35 combat performance in active theaters validated the platform's franchise value. Full-year 2026 guidance was reiterated unchanged at mid-single-digit sales growth.
Demand | Revenue Growth | Margin | Capital Allocation | Capex Investment | Regulation Policy | Cost Pressure | Competitive Dynamics | |
|---|---|---|---|---|---|---|---|---|
| 2024Q4 | 6 | 4 | 5 | 3 | 1 | 4 | 3 | 1 |
| 2025Q1 | 3 | 2 | 2 | 2 | 1 | 2 | ||
| 2025Q2 | 3 | 2 | 3 | 3 | 3 | 2 | ||
| 2025Q3 | 2 | 6 | 5 | 2 | 3 | 1 | 2 | |
| 2025Q4 | 3 | 2 | 2 | 5 | 3 | 1 | 1 | 1 |
| 2026Q1 | 2 | 4 | 2 | 2 | 4 | 1 | 2 | 3 |
| '24Q4 | '25Q1 | '25Q2 | '25Q3 | '25Q4 | '26Q1 | |
|---|---|---|---|---|---|---|
| Demand | 6 | 3 | 3 | 2 | 3 | 2 |
| Revenue Growth | 4 | 2 | 6 | 2 | 4 | |
| Margin | 5 | 2 | 5 | 2 | 2 | |
| Capital Allocation | 3 | 3 | 2 | 5 | 2 | |
| Capex Investment | 1 | 2 | 3 | 3 | 4 | |
| Regulation Policy | 4 | 2 | 3 | 1 | 1 | 1 |
| Cost Pressure | 3 | 1 | 3 | 2 | 1 | 2 |
| Competitive Dynamics | 1 | 2 | 2 | 1 | 3 |
| Company | Score | Trend | Rev YoY |
|---|---|---|---|
LMT Lockheed Martin | 4 | +0.3% | |
| AXON Axon Enterprise Inc. | 10 | +33.8% | |
| BA The Boeing Company | 7 | +14.0% | |
| GD General Dynamics | 8 | +10.3% | |
| GE GE Aerospace | 7 | +24.7% | |
| HII Huntington Ingalls Industries | 6 | +13.3% | |
| LHX L3Harris | 8 | +11.9% | |
| NOC Northrop Grumman | 6 | +4.4% | |
| RTX RTX Corporation | 9 | +8.7% | |
| TDG TransDigm Group | 10 | +18.3% | |
| TXT Textron | 7 | +11.8% |